Literature DB >> 21786109

Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.

Wilfried Budach1, Edwin Bölke, Rainer Fietkau, Andre Buchali, Thomas G Wendt, Wolfgang Popp, Christiane Matuschek, Horst Sack.   

Abstract

INTRODUCTION: A number of national and international societies have published recommendations regarding the required equipment and manpower that is assumed to be necessary to treat a specific number of patients with radiotherapy. None of these recommendations were based on actual time measurements needed for specific radiotherapy procedures. The German Society of Radiation Oncology (DEGRO) was interested in substantiating their recommendations by prospective evaluations of all important core procedures of radiotherapy in the most frequent cancer treated by radiotherapy. The results of the examinations of radiotherapy in head and neck cancer (HNC) patients are presented in this manuscript. PATIENTS AND METHODS: Four radiation therapy centers (University of Jena, University of Erlangen, University of Düsseldorf and the community hospital of Neuruppin) participated in this prospective study. Working time of the different occupational groups and room occupancies for the core procedures of radiotherapy in HNC were prospectively documented during a 4-month period and subsequently statistically analyzed.
RESULTS: The time needed per patient varied considerably between individual patients and between centers for all evaluated procedures. Room occupancy, presence of technicians, and overall medical staff times were 21 min, 26 min, and 42 min, respectively, for planning CT with i.v. contrast medium (n = 79), and 23 min, 44 min, and 51 min respectively, for planning CT without contrast medium (n = 45). Definition of the target volume (n = 91) was the most time consuming procedure for the physicians taking 1 h 45 min on average. Medical physicists spent a mean time of 3 h 8 min on physical treatment planning (n = 97) and 1 h 8 min on authorization of the treatment plan (n = 71). Treatment simulations (n = 185) required an average room occupancy of 23 min, and a mean technicians presence of 47 min. The mean room occupancy (n = 84) was 24 min for the first radiotherapy including portal imaging associated with a mean presence of the technicians of 53 min. For routine radiotherapy sessions (n = 2,012) and routine radiotherapy sessions including portal imaging (n = 407), mean room occupancies were 13 min and 16 min, respectively. The presence of increasing number of technicians was significantly associated with shorter room occupancy. IMRT including portal imaging (n = 213) required an average room occupancy of 24 min and a mean technician time of 48 min.
CONCLUSION: The data presented here allow an estimate of the required machine time and manpower needed for the core procedures of radiotherapy in an average head and neck cancer patient treated with a specific number of fractions. However, one has to be aware that a number of necessary and time consuming activities were not evaluated in the present study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21786109     DOI: 10.1007/s00066-011-2273-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  23 in total

1.  Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources.

Authors:  R Esco; A Palacios; J Pardo; A Biete; J A Carceller; C Veiras; G Vazquez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-06-01       Impact factor: 7.038

Review 2.  The cost of radiation therapy.

Authors:  Nicolas Paul Ploquin; Peter Brian Dunscombe
Journal:  Radiother Oncol       Date:  2008-01-30       Impact factor: 6.280

3.  Radiation oncology: future needs and equipment. Current situation in Spain.

Authors:  Amalia Palacios Eito; María Espinosa Calvo; Ana Mañas Rueda; Manuel de Las Heras
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

4.  Time and motion study of radiotherapy delivery: Economic burden of increased quality assurance and IMRT.

Authors:  Evelyn Van de Werf; Yolande Lievens; Jan Verstraete; Kris Pauwels; Walter Van den Bogaert
Journal:  Radiother Oncol       Date:  2009-09-03       Impact factor: 6.280

5.  High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer.

Authors:  Hendrik Andreas Wolff; Jan Bosch; Klaus Jung; Tobias Overbeck; Steffen Hennies; Christoph Matthias; Clemens F Hess; Ralph M Roedel; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

6.  Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population.

Authors:  Nicola Dinapoli; Claudio Parrilla; Jacopo Galli; Rosa Autorino; Francesco Miccichè; Francesco Bussu; Mario Balducci; Lucia D'Alatri; Raffaella Marchese; Mario Rigante; Giuseppe Di Lella; Luca Liberati; Giovanni Almadori; Gaetano Paludetti; Vincenzo Valentini
Journal:  Strahlenther Onkol       Date:  2010-11-08       Impact factor: 3.621

7.  Cost comparison of curative therapies for localized prostate cancer in Japan: a single-institution experience.

Authors:  Takefumi Satoh; Hiromichi Ishiyama; Kazumasa Matsumoto; Ken-ichi Tabata; Masashi Kitano; Masatsugu Iwamura; Masaki Kimura; Satoru Minamida; Hideyuki Yamashita; Daisuke Matsuda; Shouko Kotani; Yuzuru Niibe; Mineko Uemae; Kazushige Hayakawa; Shiro Baba
Journal:  Jpn J Radiol       Date:  2009-11-27       Impact factor: 2.374

8.  Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?

Authors:  P Boyle; A d'Onofrio; P Maisonneuve; G Severi; C Robertson; M Tubiana; U Veronesi
Journal:  Ann Oncol       Date:  2003-08       Impact factor: 32.976

9.  A cost-outcome analysis of Image-Guided Patient Repositioning in the radiation treatment of cancer of the prostate.

Authors:  Nicolas Ploquin; Peter Dunscombe
Journal:  Radiother Oncol       Date:  2009-05-04       Impact factor: 6.280

10.  Profile of radiotherapy departments contributing to the Cooperative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.

Authors:  J Bernier; J C Horiot; H Bartelink; K A Johansson; L Cionini; D Gonzalèz Gonzalèz; H Hamers; W van den Bogaert
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-03-01       Impact factor: 7.038

View more
  21 in total

1.  Evaluation of time, attendance of medical staff and resources for radiotherapy in pediatric and adolescent patients. The DEGRO-QUIRO trial.

Authors:  Angelika Zabel-du Bois; Stefanie Milker-Zabel; Frank Bruns; Hans Christiansen; Iris Ernst; Normann Willich; Wolfgang Popp; Jürgen Debus; Horst Sack
Journal:  Strahlenther Onkol       Date:  2014-04-01       Impact factor: 3.621

2.  Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: the DEGRO-QUIRO trial.

Authors:  L Keilholz; J Willner; H-J Thiel; N Zamboglou; H Sack; W Popp
Journal:  Strahlenther Onkol       Date:  2013-10-16       Impact factor: 3.621

3.  [Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery : QUIRO-DEGRO Trial].

Authors:  A Zabel-du Bois; S Milker-Zabel; M Henzel; W Popp; J Debus; H Sack; R Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2012-08-01       Impact factor: 3.621

4.  The QUIRO Study (assurance of quality and innovation in radiooncology): methodology, instruments and practices.

Authors:  J Dunst; N Willich; H Sack; R Engenhart-Cabillic; V Budach; W Popp
Journal:  Strahlenther Onkol       Date:  2014-01-11       Impact factor: 3.621

5.  Evaluation of time, attendance of medical staff, and resources during interstitial brachytherapy for prostate cancer : DEGRO-QUIRO trial.

Authors:  N Tselis; U Maurer; W Popp; H Sack; N Zamboglou
Journal:  Strahlenther Onkol       Date:  2014-02-07       Impact factor: 3.621

6.  [Personnel requirements of medical radiation physics in radiotherapy in comparison to the current guidelines "radiation protection in medicine" : Special consideration of intensity-modulated radiation therapy].

Authors:  H-K Leetz; H H Eipper; H Gfirtner; P Schneider; K Welker
Journal:  Strahlenther Onkol       Date:  2014-05-08       Impact factor: 3.621

7.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial.

Authors:  E Blank; N Willich; R Fietkau; W Popp; J Schaller-Steiner; H Sack; F Wenz
Journal:  Strahlenther Onkol       Date:  2012-01-14       Impact factor: 3.621

8.  Protection of quality and innovation in radiation oncology: the prospective multicenter trial QUIRO of DEGRO: evaluation of time, attendance of medical staff, and resources during radiotherapy with tomotherapy.

Authors:  Cornelia Winkler; M N Duma; W Popp; H Sack; V Budach; M Molls; S Kampfer
Journal:  Strahlenther Onkol       Date:  2014-03-22       Impact factor: 3.621

9.  Radiotherapy infrastructure and human resources in Switzerland : Present status and projected computations for 2020.

Authors:  Niloy Ranjan Datta; Shaka Khan; Dietmar Marder; Daniel Zwahlen; Stephan Bodis
Journal:  Strahlenther Onkol       Date:  2016-07-25       Impact factor: 3.621

10.  Time evaluation of image-guided radiotherapy in patients with spinal bone metastases. A single-center study.

Authors:  H Rief; D Habermehl; K Schubert; J Debus; S E Combs
Journal:  Strahlenther Onkol       Date:  2014-01-16       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.